diabetes

As insulin costs soar, diabetics say a $35 cap on co-pays is not enough

BY: - June 15, 2022

WASHINGTON — Lacy Mason was a 21-year-old graduate student in Atlanta when she started rationing her insulin. As a Type 1 diabetic, she needs to take insulin every day for survival. But when the cost surged to $960 a month, Mason could no longer afford it. She had aged out of Medicaid and her student […]

COMMENTARY

COVID-19 is causing more type 1 diabetes in kids, who will be saddled with high insulin prices

BY: - April 14, 2022

As nurses, my husband and I witnessed truly awful and devastating things treating patients on the frontlines of this pandemic. Hundreds of thousands of Americans have died, while the millions who survived, now faced with disability, are left to grapple with the harsh realities of long COVID-19. Among those millions of people living with long-term health impacts […]

$35 insulin cap is welcome, popular, and bipartisan. But Congress may not pass it anyway.

BY: - March 8, 2022

By Michael McAuliff, Kaiser Health News Democrats in the Senate are primed this month to make their first attempt at salvaging one of the most popular elements of President Joe Biden’s stalled Build Back Better plan — the proposal to cap insulin costs at $35 a month. It might not go well. That’s true even […]

Bipartisan senators introduce bill to price cap insulin cost share

BY: - September 2, 2021

A bipartisan pair of state Senators introduced legislation Monday to cap the prices health insurers can charge people with diabetes for their insulin. Senate Bill 220, if passed, would prohibit insurers from charging more than $35 for a 30-day supply of insulin. The bill, less than 100 words in length, could save thousands annually for […]

Ohio Democrats look to wrangle down insulin costs

BY: - February 25, 2020

Democrats in the state House and Senate are pushing legislation that would force insurers to cap patients’ cost-sharing on insulin at $100 for a 30-day supply. The House Health Committee held its first review on the lower chamber’s bill last week, one of several pieces of legislation to address skyrocketing insulin costs in the U.S. […]